UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026

Commission file number: 001-34958

EASON TECHNOLOGY LIMITED

Room 612, 6/F, KaiYue Comm Building, No. 2C,

Argyle Street, Mongkok Kowloon, Hong Kong,

People’s Republic of China

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40- F.

Form 20-F ☒ Form 40-F ☐

~~Submission~~Departure of ~~Matters~~Directors; toAppointment ~~a Vote~~ of ~~Security Holders.~~Directors

~~The~~Effective ~~Company held its 2026 annual general meeting at 10:00 a.m., Eastern Time,~~ on March 18, 2026 ~~at the Company’s office at 27th Floor~~, ~~Lianfa~~Yuan ~~International~~Gao ~~Building,~~resigned ~~128~~from ~~Xudong~~his ~~Road,~~position ~~Wuchang~~as ~~District,~~a ~~Wuhan~~member ~~City, Hubei Province, People’s Republic~~ of ~~China.~~the ~~Holders~~board of adirectors ~~total of 163,345,295,776 class A ordinary shares, par value $0.00005 each~~ (the “~~Class A Ordinary Shares~~Board”) ~~and~~of ~~512,232,237~~Eason ~~class~~Technology ~~B ordinary shares, par value $0~~Ltd.~~00005~~ ~~each~~ (the “~~Class B Ordinary Shares~~Company”)~~, out~~. ofMr. aYuan ~~total~~Gao’s ofresignation ~~174,077,555,803~~was ~~Class~~not ~~A Ordinary Shares and 512,232,237 Class B Ordinary Shares issued and outstanding and entitled to vote as of~~ the ~~record~~result ~~date~~ of ~~January~~any ~~30,~~disagreement ~~2026~~with ~~were present at~~ the ~~Meeting,~~Company ~~and~~on aany ~~quorum~~matter ~~for~~relating ~~the transaction of business was present. Each Class A ordinary share is entitled~~ to ~~one~~the ~~vote~~Company’s operations, ~~and~~policies ~~each~~or ~~Class B ordinary share is entitled to fifty votes~~practices.

1.As Repreviously disclosed in the Company’s Form 6-~~election~~K filed with the Securities and Exchange Commission on March 18, 2026, Haitao He (“Mr. He”) was elected as a director of ~~directors~~the Company subject to renewal at the Company’s next annual general meeting. The Board has determined that Mr. He qualifies as an independent director under the NYSE American LLC Company Guide. Mr. He will receive a monthly compensation of $10,000 for his service as a director of the Board, pursuant to the offer letter between Mr. He and the Company (the “Offer Letter”).

~~The~~Mr. ~~following~~Haitao ~~individuals~~He ~~were~~is ~~re-elected~~a orpharmaceutical ~~elected~~industry professional with 10+ years of experience in marketing, sales channel development, and business operations. He previously served as ~~directors~~Marketing toManager ~~serve~~at onSichuan ~~the~~Datong ~~Board~~Xinhong ofPharmaceutical ~~Directors~~Group, expanding networks across agents, hospitals, and pharmacies. Since 2019, he has been General Manager of ~~the~~Midou ~~Company~~Industry (Shanghai) Co., toLtd., ~~hold~~where ~~office~~he ~~for~~built a ~~one~~pharmaceutical e-~~year~~commerce ~~term~~platform, ~~subject~~expanded domestic and overseas supply channels, and developed an end-to-end ~~renewal~~pharmaceutical atcirculation ~~the~~supply ~~Company’s~~chain. ~~next~~Mr. ~~annual~~He ~~general~~holds ~~meeting~~a Bachelor of Science in Pharmacy from Chengdu Medical College in 2013.

Director’s Name	For		Against		Abstain
Longwen (Stanley) He		188,200,427,626		723,300,000		33,180,000
Stephen Liao		188,200,427,626		723,300,000		33,180,000
Jun Hu		188,200,427,626		723,300,000		33,180,000
Hao Xu		188,135,147,626		788,580,000		33,180,000
Siyuan Xu		188,200,427,626		723,300,000		33,180,000
Halen Fu		188,195,747,626		727,980,000		33,180,000
Haitao He		188,200,427,626		723,300,000		33,180,000

There is no family relationship between Mr. He and any of our other officers and directors.

2.The ~~That~~foregoing ~~conditional~~description ~~upon~~of the ~~registration~~Offer byLetter ~~the~~is ~~Registrar~~a ofgeneral ~~Companies~~description ofonly, ~~the~~does ~~Cayman~~not ~~Islands~~purport ofto ~~the~~be ~~solvency~~complete, ~~statement~~ and ~~minute~~is ~~containing~~qualified ~~the~~in ~~particulars~~its ~~required~~entirety ~~under~~by ~~the~~reference ~~Companies~~to ~~Act~~the ~~(As~~term ~~Revised)~~ of the ~~Cayman~~Offer ~~Islands~~Letter ~~with~~attached ~~respect~~hereto toas ~~the~~Exhibits ~~Capital~~4.1, ~~Reduction~~which ~~(as~~is ~~defined~~incorporated ~~below):~~herein by reference.

a) the par value of each authorized and issued share in the capital of the Company be reduced from US$0.00005 per share to US$0.0000005 per share such that the issued share capital be reduced by cancelling the paid-up capital of the Company to the extent of US$0.0000495 on each of the then issued shares of the Company (the “Capital Reduction”); b) the credit arising from the Capital Reduction be transferred to a distributable reserve account of the Company which may be utilized by Company as the board of directors of the Company may deem fit and permitted under the Companies Act (As Revised) of the Cayman Islands, the Memorandum and Articles of Association of the Company and all relevant applicable laws, including, without limitation, eliminating or setting off any accumulated losses of the Company (if any) from time to time; c) immediately following the Capital Reduction, each of the authorized but unissued shares in the capital of the Company be sub-divided into 100 shares of a par value of US$0.0000005 each (the “Share Sub-Division”); d) immediately following the Capital Reduction and the Share Sub-Division, the authorized share capital of the Company shall be changed, FROM: US$40,000,000 divided into (i) 780,000,000,000 Class A Ordinary Shares of a par value of US$0.00005 each, and (ii) 20,000,000,000 Class B Ordinary Shares of a par value of US$0.00005 each, TO: US$400,000 divided into (i) 780,000,000,000 Class A Ordinary Shares of a par value of US$0.0000005 each (the "New Class A Ordinary Shares"), and (ii) 20,000,000,000 Class B Ordinary Shares of a par value of US$0.0000005 each (the "New Class B Ordinary Shares") by cancelling the excess authorized but unissued shares in the authorized share capital of the Company, and of which 174,077,555,803 New Class A Ordinary Shares and 512,232,237 New Class B Ordinary Shares are issued and are fully paid up and the remainder are unissued; and e) each of the New Class A Ordinary Shares and the New Class B Ordinary Shares arising from the Capital Reduction shall rank pari passu in all respects with each other respectively and shall have the rights and privileges and be subject to the restrictions as contained in the Memorandum and Articles of Association of the Company.

The shareholders approved the proposal.

For		Against		Abstain
187,995,767,626		955,020,000		6,120,000

3. Subject to the Capital Reduction and Share Sub-Division taking effect, to approve and adopt the Fifth Amended and Restated Memorandum and Articles of Association of the Company, a form of which is attached hereto Exhibit 3.1 in substitution for the existing Fourth Amended and Restated Memorandum and Articles of Association of the Company, to reflect the Capital Reduction and the Share Sub-Division;

The shareholders approved the proposal.

For		Against		Abstain
188,025,827,626		897,960,000		33,120,000

4. To approve the 2026 Equity Incentive Plan.

The shareholders approved the proposal.

For		Against		Abstain
188,061,167,626		868,620,000		27,120,000

Exhibit Index

Exhibit No.		Description
3.1		Form of the Fifth Amended and Restated Memorandum and Articles of Association of the Company
4.1		Form of the Offer Letter

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Eason Technology Limited
Date: March 18, 2026	By:	/s/ Longwen (Stanley) He
Date: March 19, 2026	By:	/s/ Longwen (Stanley) He
	Name:	Longwen (Stanley) He
	Title:	Chief Executive Officer

Filing Compare · Eason Technology Ltd